Navigation Links
Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
Date:8/14/2008

>

related to discontinued

operations (net of

income tax of $218,060) - 1,534,476 - 1,155,973

Net (loss) income $(1,570,651) $1,550,919 $(2,911,756) $912,833

(Loss) income per share

from continuing

operations - basic $(0.72) $0.01 $(1.33) $(0.12)

Income per share from

discontinued operations

- basic - 0.74 - 0.56

Net (loss) income per

share - basic $(0.72) $0.75 $(1.33) $0.44

(Loss) income per share

from continuing operations

- diluted $(0.72) $0.01 $(1.33) $(0.12)

Income per share from

discontinued operations -

diluted - 0.67 - 0.56

Net (loss) income per share

- diluted $(0.72) $0.68 $(1.33) $0.44

Weighted average number of

shares used to calculate

(loss) income per share

- basic 2,193,598 2,065,425 2,192,883 2,065,425

Weighted average number of

shares used to calculate

(loss) income per share

- diluted 2,193,598 2,296,930 2,192,883 2,065,425

Consolidated Balance Sheets

June 30, December 31,

ASSETS 2008 2007

CURRENT ASSETS

Cash and cash equivalents $2,835,771 $5,424,486

Accounts receivable 122,958 118,471

Inventories 676,516 172,548

Deposits 15,472 553,483

Prepaid income taxes 58,463 56,863

Income ta
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
2. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
3. Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney
4. RADI Medical Systems Launches Next Generation PressureWire(R) Certus
5. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
6. InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
7. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
8. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
9. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
10. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
11. Pressure BioSciences, Inc. to Discuss 2007 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Belgium , Nov. 24, 2014 ... on developing diagnostic tests for cancer and other conditions, today ... be presented at the Science for Business BioWin Day 2014, ... . The data come from VolitionRx,s lung cancer pilot ... department of the Centre Hospitalier Universitaire (CHU) de Liege in ...
(Date:11/24/2014)... 2014 Deep Research Report on Global ... and in-depth research report on the Adipic Dihydrazide ... definition, classification, application, and industry chain structure as ... international market analysis, including China’s domestic market as ... Asia, China, Japan etc. regions) industry analysis covering ...
(Date:11/22/2014)... 2014 Two new educational webinars hosted by ... for ALS research and how the pharmaceutical industry can make ... Bucket Challenge: Where Does the ALS Money Go? , Featuring ... 2014, Time: 1:30pm ET, Register to attend , ... Merit Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts General ...
(Date:11/22/2014)... On November 17th Chicago start-up Briteseed ... Medical Technologies Summit in San Francisco to take first ... among Silicon Valley investors and technology elites as the ... also positions Briteseed to move on to the ... and compete with other elite innovation finalists for a ...
Breaking Biology Technology:VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 2Adipic Dihydrazide Industry 2019 Research Forecasts on Worldwide, China Regions Now Available at ReportsnReports.com 3DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3
... Third Quarter Net Revenues Up 98% and Adjusted ... 12 /Xinhua-PRNewswire/ -- WuXi PharmaTech,(Cayman) Inc. (NYSE: ... research and development outsourcing company with operations,in China ... financial,results for the third quarter ended September 30, ...
... Beckman,Coulter, Inc. (NYSE: BEC ), a ... simplify, automate, and innovate complex biomedical,testing, announced ... vice,president and chief financial officer, will present ... Conference on Tuesday, November 18, 2008 at,4:40 ...
... LINCOLN, Neb., Nov. 12 Protease substrates provide ... of inhibitors,and screen compound collections for discovery of ... NIR-FRET Protease Substrates:,IRDye 800CW/QC-1 HIV-1, IRDye 800CW/QC-1 BACE, ... low intrinsic fluorescence due to self-quenching,of the conjugated ...
Cached Biology Technology:WuXi PharmaTech Announces Third Quarter 2008 Results 2WuXi PharmaTech Announces Third Quarter 2008 Results 3WuXi PharmaTech Announces Third Quarter 2008 Results 4WuXi PharmaTech Announces Third Quarter 2008 Results 5WuXi PharmaTech Announces Third Quarter 2008 Results 6WuXi PharmaTech Announces Third Quarter 2008 Results 7WuXi PharmaTech Announces Third Quarter 2008 Results 8WuXi PharmaTech Announces Third Quarter 2008 Results 9WuXi PharmaTech Announces Third Quarter 2008 Results 10WuXi PharmaTech Announces Third Quarter 2008 Results 11WuXi PharmaTech Announces Third Quarter 2008 Results 12WuXi PharmaTech Announces Third Quarter 2008 Results 13LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates 2
(Date:11/21/2014)...   Atmel® Corporation (NASDAQ: ATML ... technology solutions, today launched the industry,s first family of ... V cc range from 1.7V to 5.5V. The ... 2 C bus communication speeds, and are available with ... ideal for consumer, industrial, computer, and medical applications. ...
(Date:11/18/2014)... 2014 The Parenteral Drug Association (PDA) today confirmed ... speak and at least seven more will participate in the ... Shoreham Hotel in Washington D.C. , Dec. ... significant support from the regulatory agencies in the ... in our effort to help advance the use of metrics ...
(Date:11/12/2014)... PALM BEACH GARDENS, Fla. , Nov. 12, 2014 ... management solutions, announced today that its U.are.U ® ... upscale retail bakery chain in Central Mexico ... solution in June 2014 to eliminate payroll issues caused ... Prior to installing the U.are.U fingerprint readers, Montparnasse ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... Biomedical and Chemical Engineering at L.C. Smith College of ... commonly used nanoparticles, particles up to one million times ... damage cell membranes. In a recent article ... Langmuir entitled "Effects of nanoparticle charge and ...
... A study led by Robert G. Hawley, Ph.D., ... and regenerative biology at the George Washington University ... may help predict which patients with multiple myeloma ... titled "Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma ...
... MA) -- Microbiologists who study wild marine microbes, as opposed ... clear picture of the daily activities of their subjects. But ... Aquarium Research Institute recently figured out how to make the ... many coexisting species in their native habitat over time. ...
Cached Biology News:Modifications of a nanoparticle can change chemical interactions with cell membranes 2New research may aid treatment of multiple myeloma patients 2New research may aid treatment of multiple myeloma patients 3Microbiologists eavesdrop on the hidden lives of microbes 2Microbiologists eavesdrop on the hidden lives of microbes 3